These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 30953797)

  • 1. Elimination of ghost peaks by optimization of anion exchange chromatography method for determination of gamma-carboxyglutamic acid (Gla)-domainless impurity in recombinant activated clotting factor VII drug products.
    Tahmasbi H; Zarezadeh N; Marjaninia S; Molavi B; Maleknia S; Mahboudi F; Behrouz H
    J Pharm Biomed Anal; 2019 Jul; 171():1-7. PubMed ID: 30953797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Forced degradation and impurity profiling: recent trends in analytical perspectives.
    Jain D; Basniwal PK
    J Pharm Biomed Anal; 2013 Dec; 86():11-35. PubMed ID: 23969330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accumulation of the recombinant factor VIIa in rat bone: importance of the Gla-domain and relevance to factor IX, another vitamin K-dependent clotting factor.
    Thomsen MK; Wildgoose P; Nilsson P; Hedner U
    Pharmacol Toxicol; 1993 Sep; 73(3):127-32. PubMed ID: 7903449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoclonal antibody (VII-M31) to bovine factor VII: a specific epitope in the gamma-carboxyglutamic acid domain.
    Higashi S; Kawabata S; Nishimura H; Funasaki H; Ohyama S; Miyamoto S; Funatsu A; Iwanaga S
    J Biochem; 1990 Oct; 108(4):654-62. PubMed ID: 1705545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. gamma-Carboxyglutamic acid (Gla)-domainless blood coagulation factor IXa species: preparation and properties.
    Morita T; Fukudome K; Miyata T; Iwanaga S
    J Biochem; 1991 Dec; 110(6):990-6. PubMed ID: 1794990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stable adducts of nerve agents sarin, soman and cyclosarin with TRIS, TES and related buffer compounds--characterization by LC-ESI-MS/MS and NMR and implications for analytical chemistry.
    Gäb J; John H; Melzer M; Blum MM
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 May; 878(17-18):1382-90. PubMed ID: 20172768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcium binding to a human factor IXa derivative lacking gamma-carboxyglutamic acid: evidence for two high-affinity sites that do not involve beta-hydroxyaspartic acid.
    Morita T; Kisiel W
    Biochem Biophys Res Commun; 1985 Jul; 130(2):841-7. PubMed ID: 3875344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-performance liquid chromatography--mass spectrometry and electron-capture dissociation tandem mass spectrometry of osteocalcin. Determination of gamma-carboxyglutamic acid residues.
    Niiranen H; Budnik BA; Zubarev RA; Auriola S; Lapinjoki S
    J Chromatogr A; 2002 Jul; 962(1-2):95-103. PubMed ID: 12198976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. gamma-Carboxyglutamic acids 36 and 40 do not contribute to human factor IX function.
    Gillis S; Furie BC; Furie B; Patel H; Huberty MC; Switzer M; Foster WB; Scoble HA; Bond MD
    Protein Sci; 1997 Jan; 6(1):185-96. PubMed ID: 9007991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and characterization of wild-type and variant gamma-carboxyglutamic acid-containing domains of factor VII.
    Martin DM; O'Brien DP; Tuddenham EG; Byfield PG
    Biochemistry; 1993 Dec; 32(50):13949-55. PubMed ID: 8268171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancing recovery of recombinant hepatitis B surface antigen in lab-scale and large-scale anion-exchange chromatography by optimizing the conductivity of buffers.
    Mojarrad Moghanloo GM; Khatami M; Javidanbardan A; Hosseini SN
    Protein Expr Purif; 2018 Jan; 141():25-31. PubMed ID: 28870699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On-line two-dimensional capillary strong anion exchange/reversed phase liquid chromatography-tandem mass spectrometry for comprehensive lipid analysis.
    Bang DY; Moon MH
    J Chromatogr A; 2013 Oct; 1310():82-90. PubMed ID: 24001943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation of Gla-domainless FVIIa by cathepsin G-mediated cleavage.
    Nicolaisen EM; Petersen LC; Thim L; Jacobsen JK; Christensen M; Hedner U
    FEBS Lett; 1992 Jul; 306(2-3):157-60. PubMed ID: 1633870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A full-scale tracing study of "ghost peaks" encountered in impurity analysis of budesonide based on experimental operation inspection-liquid chromatography/mass spectrometry fingerprint-mechanism based stress studies integrated strategy.
    Zhang L; Hu Q; Wang J; Zhang H; Han J
    J Sep Sci; 2022 Jul; 45(13):2128-2139. PubMed ID: 35396795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel two-dimensional liquid chromatography - Mass spectrometry method for direct drug impurity identification from HPLC eluent containing ion-pairing reagent in mobile phases.
    Long Z; Zhan Z; Guo Z; Li Y; Yao J; Ji F; Li C; Zheng X; Ren B; Huang T
    Anal Chim Acta; 2019 Feb; 1049():105-114. PubMed ID: 30612641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Supercritical fluid chromatography-photodiode array detection-electrospray ionization mass spectrometry as a framework for impurity fate mapping in the development and manufacture of drug substances.
    Pirrone GF; Mathew RM; Makarov AA; Bernardoni F; Klapars A; Hartman R; Limanto J; Regalado EL
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Mar; 1080():42-49. PubMed ID: 29477066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-affinity calcium-binding site in the gama-carboxyglutamic acid domain of bovine factor VII.
    Inoue K; Shimada H; Ueba J; Enomoto S; Tanaka-Saisaka Y; Kubota T; Koyama M; Morita T
    Biochemistry; 1996 Oct; 35(43):13826-32. PubMed ID: 8901525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolation and characterization of the reaction product of 4-diazobenzenesulfonic acid and gamma-carboxyglutamic acid: modification of the assay for measurement of beta-carboxyaspartic acid.
    Nishimoto SK; Zhao J; Dass C
    Anal Biochem; 1994 Jan; 216(1):159-64. PubMed ID: 8135347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification, characterization and quantification of a new impurity in deferasirox active pharmaceutical ingredient by LC-ESI-QT/MS/MS.
    Thomas S; Chandra Joshi S; Vir D; Agarwal A; Rao RD; Sridhar I; Xavier CM; Mathela CS
    J Pharm Biomed Anal; 2012 Apr; 63():112-9. PubMed ID: 22361658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. gamma-Carboxyglutamate excretion and warfarin therapy.
    Levy RJ; Lian JB
    Clin Pharmacol Ther; 1979 May; 25(5 Pt 1):562-70. PubMed ID: 373941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.